Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, giving stable, substantial-purity components for growing older and cancer research. Daily laboratory workflows generally reveal a persistent challenge: the gradual and inefficient removal of senescent cells that impair ti